Medical Abortion Clinical Trial
Official title:
Insertion of an IUD After Medical Abortion
The purpose of this study is to determine the expulsion and continuation rate of an
intruterine device (IUD) placed immediately after medical abortion.
Our hypothesis is that immediate-placement of an IUD after completed medical abortion will
have a similar expulsion and continuation rate to traditional placement (4-6 weeks after
pregnancy).
Women who seek abortion care often desire more effective or longer- lasting contraception. Intrauterine devices are as efficacious as tubal ligation, require no on-going effort on the woman's part to protect her from pregnancy, and are underutilized in the US. We are interested in determining whether placement of an intreatuereine device (IUD) at the time of confirming the completion of a medical abortion may have similar expulsion and continuation rates as IUDs placed after pregnancy (usually a 4-6 week time period). If this is the case, women may save the time and effort of yet another clinic visit, as well as have immediate protection against pregnancy after their abortion. FDA labeling does not specify or restrict time of insertion and therefore this study is in compliance with FDA labeling. ;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02745093 -
Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks
|
Phase 4 | |
Completed |
NCT02570204 -
Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests
|
N/A | |
Completed |
NCT01487213 -
Routine Follow-up Versus Self-assessment in Medical Abortion
|
N/A | |
Terminated |
NCT05119439 -
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
|
Phase 4 | |
Terminated |
NCT04941443 -
Methadone and Medication Abortion
|
Phase 4 | |
Completed |
NCT02985229 -
Acceptability and Feasibility of Medical Abortion in Singapore
|
Phase 3 | |
Completed |
NCT01920022 -
Quickstart of Nexplanon® at Medical Abortion
|
Phase 4 | |
Completed |
NCT00472394 -
Determining Women's Preferences for Medical Abortion Using Willingness to Pay
|
N/A | |
Completed |
NCT03604341 -
Cannabinoids for Pain Control During Medical Abortion
|
Phase 4 | |
Completed |
NCT00907725 -
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
|
N/A | |
Completed |
NCT00120224 -
De-Medicalizing Mifepristone Medical Abortion
|
N/A | |
Completed |
NCT03148587 -
Medical Abortion Self-Confirmation (MASC)
|
N/A | |
Completed |
NCT02343913 -
Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan
|
N/A | |
Completed |
NCT01856777 -
Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy
|
N/A | |
Recruiting |
NCT00920465 -
Treatment Regimens for Mifegyne and Cytotec
|
Phase 3 | |
Completed |
NCT05532085 -
Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
|
||
Completed |
NCT00997347 -
The Extended Gestational Age Medical Abortion Study
|
Phase 4 | |
Completed |
NCT03014193 -
Simplifying First Trimester Medical Abortion Follow-up
|
N/A | |
Recruiting |
NCT04905251 -
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
|
||
Completed |
NCT04181541 -
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
|
N/A |